Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms

Míreanna comhchosúla

• Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
  de réir: Hinds, David A., et al.
  Foilsithe / Cruthaithe: (2016)
• JAK2(V617F)-mutant Vascular Niche Contributes to JAK2(V617F) Clonal Expansion in Myeloproliferative Neoplasms
  de réir: Lin, Chi Hua Sarah, et al.
  Foilsithe / Cruthaithe: (2016)
• Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease
  de réir: Yokokawa, Tetsuro, et al.
  Foilsithe / Cruthaithe: (2021)
• The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
  de réir: Jamieson, Catriona H. M., et al.
  Foilsithe / Cruthaithe: (2006)
• Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2(V617F)-driven myeloproliferative disease initiation in mice
  de réir: Staehle, Hans F., et al.
  Foilsithe / Cruthaithe: (2020)